JSM 2015 Preliminary Program

Online Program Home
My Program

Abstract Details

Activity Number: 617
Type: Contributed
Date/Time: Wednesday, August 12, 2015 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract #316094
Title: Joint Evaluation of Oncology Endpoints with Multi-State Counting Process
Author(s): Xiaofei Hu* and Guang Chen and Xiaolong Luo
Companies: and Celgene and Celgene
Keywords: counting process ; oncology ; PFS ; OS
Abstract:

In the treatment of cancer which include long-term interventions, patients often switch lines of treatments due to disease progression or unacceptable toxicity. In clinical trials, the clinical endpoint, Overall Survival (OS) representing the actual clinical benefits, requires a long term follow up for evaluation. Progression Free Survival (PFS) is a popular and commonly used surrogate which allows shorter and smaller trials to meet the clinical objective. In conventional statistical methods, we study PFS and OS separately without considering their intertwining relationship and relationship with subsequent therapies. In this presentation, we will discuss a multi-state counting process methodology to study the relationship of PFS, OS and study drug exposure simultaneously. The joint relationship may help to answer how to obtain the projected longer term OS effect from the shorter term PFS effect and many other important questions. Simulations will be used to demonstrate the effectiveness of the proposed method.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2015 program





For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home